Haemonetics Corporation
HAE
$78.71
$3.835.12%
NYSE
| 03/28/2026 | 12/27/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Net Income | 97.31M | 175.44M | 168.19M | 163.34M | 167.68M |
| Total Depreciation and Amortization | 105.62M | 105.91M | 107.55M | 108.51M | 108.89M |
| Total Amortization of Deferred Charges | 6.10M | 6.70M | 6.70M | 6.70M | 6.70M |
| Total Other Non-Cash Items | 107.85M | 28.68M | 31.61M | 26.46M | 422.00K |
| Change in Net Operating Assets | -23.65M | 22.12M | -25.01M | -78.47M | -101.96M |
| Cash from Operations | 293.22M | 338.84M | 289.04M | 226.54M | 181.73M |
| Capital Expenditure | -32.78M | -30.76M | -32.96M | -37.38M | -39.28M |
| Sale of Property, Plant, and Equipment | 1.38M | 3.30M | 3.12M | 3.19M | 23.25M |
| Cash Acquisitions | -60.18M | 0.00 | 0.00 | -1.76M | -150.91M |
| Divestitures | -- | 43.29M | 43.29M | 43.29M | 43.29M |
| Other Investing Activities | -87.96M | -90.72M | -76.25M | -63.05M | -38.26M |
| Cash from Investing | -179.55M | -74.89M | -62.80M | -55.70M | -161.90M |
| Total Debt Issued | 300.00M | 0.00 | 0.00 | 0.00 | 950.00M |
| Total Debt Repaid | -306.25M | -6.25M | -6.25M | -4.69M | -502.69M |
| Issuance of Common Stock | 7.89M | 7.91M | 7.68M | 7.87M | 8.33M |
| Repurchase of Common Stock | -180.00M | -229.96M | -230.24M | -230.27M | -235.24M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -102.00K | -116.00K | -251.00K | -223.00K | -111.58M |
| Cash from Financing | -178.46M | -228.41M | -229.06M | -227.32M | 108.82M |
| Foreign Exchange rate Adjustments | 3.46M | 6.99M | -33.00K | 4.94M | -685.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -61.32M | 42.52M | -2.86M | -51.53M | 127.96M |